Cancer Epidemiology
Volume 34, Issue 1 , Pages 66-72 , February 2010

Genetic polymorphism of glutathione S-transferase T1 and the risk of colorectal cancer: A meta-analysis

  • Hongwei Wan

      Affiliations

    • West China School of Medicine Sichuan University, Chengdu 610041, Sichuan Province, China
    • ,
  • Yong Zhou

      Affiliations

    • Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, 37 Guo Xue Rd., Chengdu 610041, Sichuan Province, China
    • ,
  • Ping Yang

      Affiliations

    • West China School of Medicine Sichuan University, Chengdu 610041, Sichuan Province, China
    • ,
  • Bo Chen

      Affiliations

    • West China School of Medicine Sichuan University, Chengdu 610041, Sichuan Province, China
    • ,
  • Guiqing Jia

      Affiliations

    • West China School of Medicine Sichuan University, Chengdu 610041, Sichuan Province, China
    • ,
  • Xiaoting Wu

      Affiliations

    • Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, 37 Guo Xue Rd., Chengdu 610041, Sichuan Province, China
    • Corresponding Author InformationCorresponding author. Tel.: +86 28 85454964.

,Accepted 9 December 2009.

References 

  1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer. 2001;37:S4–66
  3. Sung JJ, Lau JY, Goh KL, Leung WK. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005;6:871–876
  4. Giacosa A, Franceschi S, La Vecchia C, Favero A, Andreatta R. Energy intake, overweight, physical exercise and colorectal cancer risk. Eur J Cancer Prev. 1999;8:S53–60
  5. Slattery ML. Diet, lifestyle, and colon cancer. Semin Gastrointest Dis. 2000;11:142–146
  6. Boutron-Ruault MC, Senesse P, Méance S, Belghiti C, Faivre J. Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer. 2001;39:50–57
  7. Giovannucci E. An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer. Cancer Epidemiol Biomark Prev. 2001;10:725–731
  8. Naccarati A, Pardini B, Hemminki K, Vodicka P. Sporadic colorectal cancer and individual susceptibility: a review of the association studies investigating the role of DNA repair genetic polymorphisms. Mutat Res. 2007;635:118–145
  9. De la Chapelle A. Genetic predisposition to colorectal cancer. Nat Rev Cancer. 2004;4:769–780
  10. Ahmed FE. Role of genes, the environment and their interactions in the etiology of inflammatory bowel diseases. Expert Rev Mol Diagn. 2006;6:345–363
  11. Hayes JD, Pulford DJ. The glutathione S-transferase supergene family: regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit Rev Biochem Mol Biol. 1995;30:445–600
  12. Eaton DL, Bammler TK. Concise review of the glutathione S-transferases and their significance to toxicology. Toxicol Sci. 1999;49:156–164
  13. Webb G, Vaska V, Coggan M, Board P. Chromosomal localization of the gene for the human theta class glutathione transferase (GSTT1). Genomics. 1996;33:121–123
  14. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. Human glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994;300:271–276
  15. Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk forcolorectal cancer increased risk in individuals with glutathione transferase theta 1 (GSTT1) gene defect (Abstract). Gastroenterology. 1997;112:A542
  16. Ferraz JM, Zinzindohoué F, Lecomte T, Cugnenc PH, Loriot MA, Beaune P, et al. Impact of GSTT1, GSTM1, GSTP1 and NAT2 genotypes on KRAS2 and TP53 gene mutations in colorectal cancer. Int J Cancer. 2004;110:183–187
  17. Lüchtenborg M, Weijenberg MP, Kampman E, van Muijen GN, Roemen GM, Zeegers MP, et al. Cigarette smoking and colorectal cancer: APC mutations, hMLH1 expression, and GSTM1 and GSTT1 polymorphisms. Am J Epidemiol. 2005;161:806–815
  18. Lee E, Huang Y, Zhao B, Seow-Choen F, Balakrishnan A, Chan SH. Genetic polymorphism of conjugating enzymes and cancer risk: GSTM1, GSTT1, NAT1 and NAT2. J Toxicol Sci. 1998;23:140–142
  19. Sgambato A, Campisi B, Zupa A, Bochicchio A, Romano G, Tartarone A, et al. Glutathione S-transferase (GST) polymorphisms as risk factors for cancer in a highly homogeneous population from southern Italy. Anticancer Res. 2002;22:3647–3652
  20. Turner F, Smith G, Sachse C, Lightfoot T, Garner RC, Wolf CR, et al. Vegetable, fruit and meat consumption and potential risk modifying genes in relation to colorectal cancer. Int J Cancer. 2004;112:259–264
  21. Fan CH, Jin MJ, Zhang Y, Song L, Xu H, Jiang QT, et al. Association between genetic polymorphisms of metabolic enzymes and susceptibility of colorectal cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2006;40:13–17
  22. Yeh CC, Sung FC, Tang R, Chang-Chieh CR, Hsieh LL. Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan. J Biomed Sci. 2007;14:183–193
  23. Chenevix-Trench G, Young J, Coggan M, Board P. Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. Carcinogenesis. 1995;16:1655–1657
  24. Deakin M, Elder J, Hendrickse C, Peckham D, Baldwin D, Pantin C, et al. Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis. 1996;17:881–884
  25. Katoh T, Nagata N, Kuroda Y, Itoh H, Kawahara A, Kuroki N, et al. Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis. 1996;17:1855–1859
  26. Gertig DM, Stampfer M, Haiman C, Hennekens CH, Kelsey K, Hunter DJ. Glutathione S-transferase GSTM1 and GSTT1 polymorphisms and colorectal cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev. 1998;7:1001–1005
  27. Abdel-Rahman SZ, Soliman AS, Bondy ML, Wu X, El-Badawy SA, Mahgoub KG, et al. Polymorphism of glutathione S-transferase loci GSTM1 and GSTT1 and susceptibility to colorectal cancer in Egypt. Cancer Lett. 1999;142:97–104
  28. Welfare M, Monesola Adeokun A, Bassendine MF, Daly AK. Polymorphisms in GSTP1, GSTM1, and GSTT1 and susceptibility to colorectal cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:289–292
  29. Zhang H, Ahmadi A, Arbman G, Zdolsek J, Carstensen J, Nordenskjöld B, et al. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma. Int J Cancer. 1999;84:135–138
  30. Butler WJ, Ryan P, Roberts-Thomson IC. Metabolic genotypes and risk for colorectal cancer. J Gastroenterol Hepatol. 2001;16:631–635
  31. Loktionov A, Watson MA, Gunter M, Stebbings WS, Speakman CT, Bingham SA. Glutathione-S-transferase gene polymorphisms in colorectal cancer patients: interaction between GSTM1 and GSTM3 allele variants as a risk-modulating factor. Carcinogenesis. 2001;22:1053–1060
  32. Saadat I, Saadat M. Glutathione S-transferase M1 and T1 null genotypes and the risk of gastric and colorectal cancers. Cancer Lett. 2001;169:21–26
  33. Laso N, Lafuente MJ, Mas S, Trias M, Ascaso C, Molina R, et al. Glutathione S-transferase (GSTM1 and GSTT1)-dependent risk for colorectal cancer. Anticancer Res. 2002;22:3399–3403
  34. Sachse C, Smith G, Wilkie MJ, Barrett JH, Waxman R, Sullivan F, et al. A pharmacogenetic study to investigate the role of dietary carcinogens in the etiology of colorectal cancer. Carcinogenesis. 2002;23:1839–1849
  35. Seow A, Yuan JM, Sun CL, Van Den Berg D, Lee HP, Yu MC. Dietary isothiocyanates, glutathione S-transferase polymorphisms and colorectal cancer risk in the Singapore Chinese Health Study. Carcinogenesis. 2002;23:2055–2061
  36. Ye Z, Parry JM. Genetic polymorphisms in the cytochrome P450 1A1, glutathione S-transferase M1 and T1, and susceptibility to colon cancer. Teratog Carcinog Mutagen. 2002;22:385–392
  37. Zhu Y, Deng C, Zhang Y, Zhou X, He X. The relationship between GSTM1, GSTT1 gene polymorphisms and susceptibility to sporadic colorectal adenocarcinoma. Zhonghua Nei Ke Za Zhi. 2002;41:538–540
  38. Nascimento H, Coy CS, Teori MT, Boin IF, Góes JR, Costa FF, et al. Possible influence of glutathione S-transferase GSTT1 null genotype on age of onset of sporadic colorectal adenocarcinoma. Dis Colon Rectum. 2003;46:510–515
  39. van der Hel OL, Bueno de Mesquita HB, Roest M, Slothouber B, van Gils C, van Noord PA, et al. No modifying effect of NAT1, GSTM1, and GSTT1 on the relation between smoking and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2003;12:681–682
  40. Chen K, Jiang QT, Ma XY, Yao KY, Leng SG, Yu WP, et al. Associations between genetic polymorphisms of glutathione S-transferase M1 and T1, smoking and susceptibility to colorectal cancer: a case–control study. Zhonghua Zhong Liu Za Zhi. 2004;26:645–648
  41. Kiss I, Németh A, Bogner B, Pajkos G, Orsós Z, Sándor J, et al. Polymorphisms of glutathione-S-transferase and arylamine N-acetyltransferase enzymes and susceptibility to colorectal cancer. Anticancer Res. 2004;24:3965–3970
  42. van der Logt EM, Bergevoet SM, Roelofs HM, van Hooijdonk Z, te Morsche RH, Wobbes T, et al. Genetic polymorphisms in UDP-glucuronosyltransferases and glutathione S-transferases and colorectal cancer risk. Carcinogenesis. 2004;25:2407–2415
  43. Ates NA, Tamer L, Ates C, Ercan B, Elipek T, Ocal K, et al. Glutathione S-transferase M1, T1, P1 genotypes and risk for development of colorectal cancer. Biochem Genet. 2005;43:149–163
  44. Rajagopal R, Deakin M, Fawole AS, Elder JB, Elder J, Smith V, et al. Glutathione S-transferase T1 polymorphisms are associated with outcome in colorectal cancer. Carcinogenesis. 2005;26:2157–2163
  45. Yeh CC, Hsieh LL, Tang R, Chang-Chieh CR, Sung FC. Vegetable/fruit, smoking, glutathione S-transferase polymorphisms and risk for colorectal cancer in Taiwan. World J Gastroenterol. 2005;11:1473–1480
  46. Huang K, Sandler RS, Millikan RC, Schroeder JC, North KE, Hu J. GSTM1 and GSTT1 polymorphisms, cigarette smoking, and risk of colon cancer: a population-based case–control study in North Carolina (United States). Cancer Causes Control. 2006;17:385–394
  47. Little J, Sharp L, Masson LF, Brockton NT, Cotton SC, Haites NE, et al. Colorectal cancer and genetic polymorphisms of CYP1A1, GSTM1 and GSTT1: a case–control study in the Grampian region of Scotland. Int J Cancer. 2006;119:2155–2164
  48. Martínez C, Martín F, Fernández JM, García-Martín E, Sastre J, Díaz-Rubio M, et al. Glutathione S-transferases mu 1, theta 1, pi 1, alpha 1 and mu 3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans. Pharmacogenomics. 2006;7:711–718
  49. Probst-Hensch NM, Sun CL, Van Den Berg D, Ceschi M, Koh WP, Yu MC. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study. Carcinogenesis. 2006;27:2475–2482
  50. Skjelbred CF, Saebø M, Hjartåker A. Meat, vegetables and genetic polymorphisms and the risk of colorectal carcinomas and adenomas. BMC Cancer. 2007;7:228
  51. Küry S, Buecher B, Robiou-du-Pont S, Scoul C, Colman H, Le Neel T, et al. Low-penetrance alleles predisposing to sporadic colorectal cancers: a French case-controlled genetic association study. BMC Cancer. 2008;8:326
  52. Epplein M, Wilkens LR, Tiirikainen M, Dyba M, Chung FL, Goodman MT, et al. Urinary isothiocyanates; glutathione S-transferase M1, T1, and P1 polymorphisms; and risk of colorectal cancer: the Multiethnic Cohort Study. Cancer Epidemiol Biomarkers Prev. 2009;18:314–320
  53. Chen K, Jiang QT, He HQ. Relationship between metabolic enzyme polymorphism and colorectal cancer. World J Gastroenterol. 2005;11:331–335
  54. Garte S. The role of ethnicity in cancer susceptibility gene polymorphisms: the example of CYP1A1. Carcinogenesis. 1998;19:1329–1332
  55. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, et al. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol. Biomarkers Prev. 2001;10:1239–1248
  56. Saadat M, Saadat I, Saboori Z, Emad A. Combination of CC16, GSTM1, and GSTT1 genetic polymorphisms is associated with asthma. J Allergy Clin Immunol. 2004;113:996–998
  57. Doney AS, Lee S, Leese GP, Morris AD, Palmer CN. Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation. 2005;111:2927–2934
  58. Raimondi S, Botteri E, Iodice S, Lowenfels AB, Maisonneuve P. Gene-smoking interaction on colorectal adenoma and cancer risk: Review and meta-analysis. Mutat Res. 2009;670:6–14
  59. Grubben MJ, Nagengast FM, Katan MB, Peters WH. The glutathione biotransformation system and colorectal cancer risk in humans. Scand J Gastroenterol Suppl. 2001;234:68–76
  60. Sherratt PJ, Manson MM, Thomson AM, Hissink EA, Neal GE, van Bladeren PJ, et al. Increased bioactivation of dihaloalkanes in rat liver due to induction of class theta glutathione S-transferase T1-1. Biochem J. 1998;335:619–630
  61. Boccia S, La Torre G, Gianfagna F, Mannocci A, Ricciardi G. Glutathione S-transferase T1 status and gastric cancer risk: a meta-analysis of the literature. Mutagenesis. 2006;21:115–123
  62. Saadat M. Genetic polymorphisms of glutathioneS-transferase T1 (GSTT1) and susceptibility to gastric cancer: a meta-analysis. Cancer Sci. 2006;97:505–509
  63. Abdel-Rahman SZ, Anwar WA, Abdel-Aal WE, Mostafa HM, Au WW. GSTM1 and GSTT1 genes are potential risk modifiers for bladder cancer. Cancer Detect Prev. 1998;22:129–138
  64. Grando JP, Kuasne H. Association between polymorphisms in the biometabolism genes CYP1A1, GSTM1, GSTT1 and GSTP1 in bladder cancer. Clin Exp Med. 2009;9:21–28
  65. Sadetzki S, Bensal D, Novikov I, Modan B. The limitations of using hospital controls in cancer etiology—one more example for Berkson's bias. Eur J Epidemiol. 2003;18:1127–1131

PII: S1877-7821(09)00185-4

doi: 10.1016/j.canep.2009.12.006

Cancer Epidemiology
Volume 34, Issue 1 , Pages 66-72 , February 2010

Article Tools

* Image Usage & Resolution